National Association of Testing Authorities, Australia
Scope of Accreditation
Asbestos Diseases Research Institute
Site
Asbestos Diseases Research Institute
Accreditation No.
20719
Site No.
24861
Date of Accreditation
12 Apr 2022
Address
Asbestos Diseases Research Institute, Bernie Banton Centre, Gate 3 Hospital Road
Concord Repatriation Hospital, NSW 2139
Australia
Contact
Availability
Services conditionally available to external clients
Supervision
Not Applicable
Scope of Accreditation
Withdrawn 02 Mar 2022
Voluntary
ISO 15189 (2012)
Human Pathology
|
|
||
| Service | Product | Determinant |
|---|---|---|
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Formalin-fixed paraffin-embedded (FFPE) tissues | MYD88 mutation analysis |
| Molecular genetics - DNA extraction | Formalin-fixed paraffin-embedded (FFPE) tissues | Viable DNA |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Formalin-fixed paraffin-embedded (FFPE) tissues | Blood borne tumours |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
20719
Site No.
24861
Print date
03 Dec 2023
